Delivery Order SPE2DB22D1017-SPE2DB25FF6CW
Award Date
2/24/25
Potential Completion Date
2/25/25
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,270.29 firm fixed-price delivery order is for GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical supplies. The contract has a completion date of January 23, 2025 and was awarded on January 22, 2025. There is no set-aside designation for this contract, indicating it was openly competed. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This is a $8,338.30 firm fixed-price delivery order issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML medical supplies, with a period of performance through May 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,565.92 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a $14,426.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a completion date of February 7, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D3101|SPE2DB24FRSV4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,385.12 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has an ultimate completion date of August 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,755.10, is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical devices. This is a firm fixed-price delivery order contract with a completion date of June 18, 2024. The contract does not have a set-aside designation, indicating open competition. As a prime contractor, AmerisourceBergen...
This is a $4,159.94 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML, a medical product, with a period of performance through January 21, 2025. This is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,002.14 firm fixed price contract is for the supply of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML medical devices. The contract has a completion date of January 3, 2024 and was awarded on January 2, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.86 firm fixed-price delivery order is for the GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML product, with a completion date of June 14, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of the product "GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML" with a ceiling value of $1,023.67 and a completion date of August 13, 2024. This order is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through...